Autopsy report · NCT05034562

Gallium-68 PSMA-11 PET in Participants With Prostate Cancer

“Per PI no participants enrolled”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

M.D. Anderson Cancer Center

Sponsor type

University, hospital or other

Conditions

Metastatic Prostate Carcinoma; Recurrent Prostate Carcinoma; Stage IV Prostate Cancer AJCC v8; Stage IVA Prostate Cancer AJCC v8; Stage IVB Prostate Cancer AJCC v8

Interventions

Computed Tomography; Gallium Ga 68-labeled PSMA-11; Magnetic Resonance Imaging; Positron Emission Tomography

Participants

0

Trials that died the same way

• A Multi-Center Protocol for Obtaining and Storing Human Samples for Immediate or Future Microbial, Immune, or Host Microbe Scientific Study
  “No participants enrolled per PI discretion” (88% match in meaning)
• A Trial of Regorafenib Plus Lorigerlimab in Patients With Locally Recurrent or Regrowing pMMR/MSS Localized Rectal Cancer
  “0 participants enrolled” (78% match in meaning)
• Validation of the Prostate Cancer Assay - Beta+Pivotal
  “No enrolled participants” (77% match in meaning)
• Thoracic Paravertebral Blocks Using a Combination of Ropivacaine and Dexmedetomidine
  “no participants enrolled” (75% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.